AAAAAA

   
Results: 1-9 |
Results: 9
NUCLEOTIDE SUBSTITUTIONS WITHIN U5 ARE CRITICAL FOR EFFICIENT REVERSETRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS)
Authors: LI Y ZHANG ZJ WAKEFIELD JK KANG SM MORROW CD
Citation: Y. Li et al., NUCLEOTIDE SUBSTITUTIONS WITHIN U5 ARE CRITICAL FOR EFFICIENT REVERSETRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS), Journal of virology, 71(9), 1997, pp. 6315-6322
MUTATIONS IN BOTH THE U5 REGION AND THE PRIMER-BINDING SITE INFLUENCETHE SELECTION OF THE TRANSFER-RNA USED FOR THE INITIATION OF HIV-1 REVERSE TRANSCRIPTION
Authors: KANG SM WAKEFIELD JK MORROW CD
Citation: Sm. Kang et al., MUTATIONS IN BOTH THE U5 REGION AND THE PRIMER-BINDING SITE INFLUENCETHE SELECTION OF THE TRANSFER-RNA USED FOR THE INITIATION OF HIV-1 REVERSE TRANSCRIPTION, Virology, 222(2), 1996, pp. 401-414
MUTATIONS WITHIN THE PRIMER BINDING-SITE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DEFINE SEQUENCE REQUIREMENTS ESSENTIAL FOR REVERSE TRANSCRIPTION
Authors: WAKEFIELD JK MORROW CD
Citation: Jk. Wakefield et Cd. Morrow, MUTATIONS WITHIN THE PRIMER BINDING-SITE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DEFINE SEQUENCE REQUIREMENTS ESSENTIAL FOR REVERSE TRANSCRIPTION, Virology, 220(2), 1996, pp. 290-298
CONSTRUCTION OF A TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS THAT MAINTAINS A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS)
Authors: WAKEFIELD JK KANG SM MORROW CD
Citation: Jk. Wakefield et al., CONSTRUCTION OF A TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS THAT MAINTAINS A PRIMER BINDING-SITE COMPLEMENTARY TO TRNA(HIS), Journal of virology, 70(2), 1996, pp. 966-975
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - CONTRIBUTION OF MET-184 TO BINDING OF NUCLEOSIDE 5'-TRIPHOSPHATE
Authors: WILSON JE AULABAUGH A CALIGAN B MCPHERSON S WAKEFIELD JK JABLONSKI S MORROW CD REARDON JE FURMAN PA
Citation: Je. Wilson et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - CONTRIBUTION OF MET-184 TO BINDING OF NUCLEOSIDE 5'-TRIPHOSPHATE, The Journal of biological chemistry, 271(23), 1996, pp. 13656-13662
HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CAN USE DIFFERENT TRANSFER-RNAS AS PRIMERS FOR REVERSE TRANSCRIPTION BUT SELECTIVELY MAINTAINS A PRIMERBINDING-SITE COMPLEMENTARY TO TRNA(3)(LYS)
Authors: WAKEFIELD JK WOLF AG MORROW CD
Citation: Jk. Wakefield et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CAN USE DIFFERENT TRANSFER-RNAS AS PRIMERS FOR REVERSE TRANSCRIPTION BUT SELECTIVELY MAINTAINS A PRIMERBINDING-SITE COMPLEMENTARY TO TRNA(3)(LYS), Journal of virology, 69(10), 1995, pp. 6021-6029
INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY THE 5'-TRIPHOSPHATE-BETA ENANTIOMERS OF CYTIDINE ANALOGS
Authors: FARAJ A AGROFOGLIO LA WAKEFIELD JK MCPHERSON S MORROW CD GOSSELIN G MATHE C IMBACH JL SCHINAZI RF SOMMADOSSI JP
Citation: A. Faraj et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE BY THE 5'-TRIPHOSPHATE-BETA ENANTIOMERS OF CYTIDINE ANALOGS, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2300-2305
MINIMAL SEQUENCE REQUIREMENTS OF A FUNCTIONAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMER BINDING-SITE
Authors: WAKEFIELD JK RHIM HS MORROW CD
Citation: Jk. Wakefield et al., MINIMAL SEQUENCE REQUIREMENTS OF A FUNCTIONAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMER BINDING-SITE, Journal of virology, 68(3), 1994, pp. 1605-1614
VIRAL GENE-PRODUCTS AND REPLICATION OF THE HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS
Authors: MORROW CD PARK J WAKEFIELD JK
Citation: Cd. Morrow et al., VIRAL GENE-PRODUCTS AND REPLICATION OF THE HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS, The American journal of physiology, 266(5), 1994, pp. 30001135-30001156
Risultati: 1-9 |